Featured Research

from universities, journals, and other organizations

Research could help improve early diagnosis of prostate cancer

Date:
February 25, 2014
Source:
University of Essex
Summary:
Prostate cancer patients could get better diagnosis and treatment for the disease in the future thanks to a successful research project. Currently, is it difficult to distinguish between benign and aggressive malignant tumors, meaning some prostate cancer patients are unnecessarily "over-treated" which can lead to needless distress and anxiety. Scientists in this field have been looking to find biomarkers to distinguish between the two types of tumors, and now prostate cancer experts have found an important link between the molecule known as BORIS and malignant tumors.

Professor Elena Klenova in her lab.
Credit: Image courtesy of University of Essex

Prostate cancer patients could get better diagnosis and treatment for the disease in the future thanks to a successful research project at the University of Essex.

Related Articles


Currently, is it difficult to distinguish between benign and aggressive malignant tumors, meaning some prostate cancer patients are unnecessarily "over-treated" which can lead to needless distress and anxiety.

Scientists in this field have been looking to find biomarkers to distinguish between the two types of tumors, and now prostate cancer experts at Essex have found an important link between the molecule known as BORIS and malignant tumors.

The research, published in the February issue of the journal Prostate, could lead the way for pathologists to have better tools for the early diagnosis of prostate cancer and for patients to get the most appropriate level of treatment for them.

The major three-year study involved the University-based Essex Biomedical Sciences Institute (EBSI) working with the Colchester Catalyst Charity and the Urology and Pathology Departments at Colchester Hospital University NHS Foundation Trust.

Leading the project at Essex was Professor Elena Klenova, who was part of the scientific team which first discovered BORIS in 2002 and its importance in prostate cancer research.

"Apart from playing an important role in the development of sperm in men, BORIS is not usually expressed in the body," explained Professor Klenova, "However, it does appear in malignant tumors, which is why it is seen as an important molecule in the development of cancer. It also can help distinguish between normal and cancerous cells."

Prostate cancer is the most common type of cancer in men. Around 37,000 UK men are diagnosed with the disease each year. Many prostate cancers develop very slowly, but in a small proportion of cases the cancer grows more quickly and spreads to other areas of the body, sometimes proving fatal.

The research was co- funded by the Colchester Catalyst Charity as part of its ongoing mission to improve the health care of people living in north-east Essex. However, the study's findings obviously have a wider impact generally for the treatment and the understanding of prostate cancer.

Professor Klenova's team at Essex, which included Zubair Cheema and Yukti Hari-Gupta, sponsored by Colchester Hospital University NHS Foundation Trust and the Colchester Catalyst Charity, respectively, looked at levels of BORIS in benign and malignant tumors and found that it was only present in malignant tumors, suggesting that the molecule could prove to be a useful biomarker for aggressive symptoms of the disease.

John Corr, consultant urological surgeon at Colchester Hospital University NHS Foundation Trust, said: "Collaborative work like this between a university and an acute hospital trust is a very under-utilised resource in the NHS, and I am very happy to be involved in it.

"This is a very exciting finding and will help in our daily fight against prostate cancer. It may more accurately identify those patients that need active treatment and aid in predicting long-term outcomes."

The scientists will now investigate the link between BORIS and malignant tumors further with a bigger study.


Story Source:

The above story is based on materials provided by University of Essex. Note: Materials may be edited for content and length.


Journal Reference:

  1. Zubair Cheema, Yukti Hari-Gupta, Georgia-Xanthi Kita, Dawn Farrar, Ian Seddon, John Corr, Elena Klenova. Expression of the cancer-testis antigen BORIS correlates with prostate cancer. The Prostate, 2014; 74 (2): 164 DOI: 10.1002/pros.22738

Cite This Page:

University of Essex. "Research could help improve early diagnosis of prostate cancer." ScienceDaily. ScienceDaily, 25 February 2014. <www.sciencedaily.com/releases/2014/02/140225101252.htm>.
University of Essex. (2014, February 25). Research could help improve early diagnosis of prostate cancer. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2014/02/140225101252.htm
University of Essex. "Research could help improve early diagnosis of prostate cancer." ScienceDaily. www.sciencedaily.com/releases/2014/02/140225101252.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins